JP2015514705A5 - - Google Patents

Download PDF

Info

Publication number
JP2015514705A5
JP2015514705A5 JP2015503159A JP2015503159A JP2015514705A5 JP 2015514705 A5 JP2015514705 A5 JP 2015514705A5 JP 2015503159 A JP2015503159 A JP 2015503159A JP 2015503159 A JP2015503159 A JP 2015503159A JP 2015514705 A5 JP2015514705 A5 JP 2015514705A5
Authority
JP
Japan
Prior art keywords
use according
heparan sulfate
chemically modified
modified heparin
heparin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015503159A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015514705A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2013/050333 external-priority patent/WO2013147690A1/en
Publication of JP2015514705A publication Critical patent/JP2015514705A/ja
Publication of JP2015514705A5 publication Critical patent/JP2015514705A5/ja
Pending legal-status Critical Current

Links

JP2015503159A 2012-03-26 2013-03-25 分娩停止の処置のための方法 Pending JP2015514705A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261615400P 2012-03-26 2012-03-26
US61/615,400 2012-03-26
PCT/SE2013/050333 WO2013147690A1 (en) 2012-03-26 2013-03-25 Method for treatment of labor arrest

Publications (2)

Publication Number Publication Date
JP2015514705A JP2015514705A (ja) 2015-05-21
JP2015514705A5 true JP2015514705A5 (cg-RX-API-DMAC7.html) 2016-05-26

Family

ID=49260784

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015503159A Pending JP2015514705A (ja) 2012-03-26 2013-03-25 分娩停止の処置のための方法

Country Status (15)

Country Link
US (1) US20150057226A1 (cg-RX-API-DMAC7.html)
EP (1) EP2830634A4 (cg-RX-API-DMAC7.html)
JP (1) JP2015514705A (cg-RX-API-DMAC7.html)
CN (1) CN104244957B (cg-RX-API-DMAC7.html)
AU (1) AU2013240598A1 (cg-RX-API-DMAC7.html)
CA (1) CA2868479A1 (cg-RX-API-DMAC7.html)
HK (1) HK1203370A1 (cg-RX-API-DMAC7.html)
MX (1) MX2014011451A (cg-RX-API-DMAC7.html)
MY (1) MY185108A (cg-RX-API-DMAC7.html)
NZ (1) NZ631279A (cg-RX-API-DMAC7.html)
RU (1) RU2014143008A (cg-RX-API-DMAC7.html)
SG (1) SG11201406118QA (cg-RX-API-DMAC7.html)
UA (1) UA117907C2 (cg-RX-API-DMAC7.html)
WO (1) WO2013147690A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201406567B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013095279A1 (en) 2011-12-19 2013-06-27 Dilafor Ab Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
SG11201405799TA (en) 2012-03-26 2014-11-27 Santen Pharmaceutical Co Ltd Ophthalmic solution comprising diquafosol
MX2014013449A (es) * 2012-05-08 2014-12-08 Dilafor Ab Tratamiento de la hemorragia postparto (pph) con heparina modificada quimicamente o sulfato de heparan y un agente uterotonico.
EP4106765A1 (en) 2020-02-17 2022-12-28 Dilafor AB Tafoxiparin for the treatment of preeclampsia
JP2025514038A (ja) 2022-05-03 2025-05-02 ディラフォール アクチエボラグ タフォキシパリンの新規な医学的使用
EP4272749A1 (en) 2022-05-03 2023-11-08 Dilafor AB New medical use of tafoxiparin
CN120603543A (zh) * 2023-02-01 2025-09-05 马特纳医疗公司 用于防止分娩期间阴道撕裂伤的方法和设备

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000065837A (ja) * 1998-08-24 2000-03-03 Seikagaku Kogyo Co Ltd グリコサミノグリカン又はグリコサミノグリカン結合性分子の測定方法及びその測定用キット
JP2000309544A (ja) * 1999-02-25 2000-11-07 Seikagaku Kogyo Co Ltd 早産または流産防止剤および子宮頚管熟化抑制剤ならびにヒアルロニダーゼの阻害剤
SE521676C2 (sv) * 2002-01-02 2003-11-25 Dilafor Ab Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
WO2009073184A1 (en) * 2007-12-03 2009-06-11 Florida State University Research Foundation, Inc. Compositions for inducing labor and associated methods
WO2013095279A1 (en) * 2011-12-19 2013-06-27 Dilafor Ab Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use

Similar Documents

Publication Publication Date Title
JP2015514705A5 (cg-RX-API-DMAC7.html)
RU2014143008A (ru) Способ лечения остановки родов
JP2015500387A5 (cg-RX-API-DMAC7.html)
JP2015500388A5 (cg-RX-API-DMAC7.html)
Pham et al. Strategies for the design of orally bioavailable antileishmanial treatments
Yang et al. Strategies for sustained release of heparin: A review
Ciccone et al. Bemiparin, an effective and safe low molecular weight heparin: a review
JP2015511664A5 (cg-RX-API-DMAC7.html)
ES2668273T3 (es) Uso de derivados de heparina químicamente modificada en drepanocitosis
RU2014129816A (ru) Неантикоагулянтные гликозаминогликаны, содержащие повторяющиеся дисахаридные звенья, и их медицинское применение
JP2011522879A5 (cg-RX-API-DMAC7.html)
JP2013536195A5 (cg-RX-API-DMAC7.html)
RU2014143017A (ru) Препараты для индукции родов
JP2013525306A5 (cg-RX-API-DMAC7.html)
Corrie et al. Harnessing the dual role of polysaccharides in treating gastrointestinal diseases: As therapeutics and polymers for drug delivery
NZ720863A (en) Anti-viral properties of aloe vera and acquired immune deficiency syndrome (aids) treatment
JP2011037849A (ja) 消化性潰瘍及び十二指腸潰瘍の治療及び予防に使用されるヒアルロン酸混合物
HRP20230820T1 (hr) Heparan-sulfat, s visokom stopom 3-o-sulfatiranja u glukozaminskim ostacima
JP2015516415A5 (cg-RX-API-DMAC7.html)
CN100341518C (zh) 硫酸化葡糖胺聚糖在制备预防和治疗足月分娩进展缓慢的药物制剂中的用途
RU2014149230A (ru) Лечение послеродового кровотечения (прк)
JP2014504613A5 (cg-RX-API-DMAC7.html)
FI3730521T3 (fi) Pentosaanipolysulfaatti ja pentosaanipolysulfaattia sisältävä lääke
Cacique et al. Heparin-hidden pillar in the management of burns
Choi et al. Low molecular weight heparin associated intramuscular hematoma with compartment syndrome